Search results

Before 2022, we used different processes for assessing technologies. You can view the previous process and methods guides below.

How providers and commissioners can use quality standards to improve the quality of care

We assess the efficacy and safety of interventional procedures used for treatment or diagnosis to determine whether they work well enough and are safe enough for use in the NHS.

Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.

We assess the value of digital health technologies that offer the greatest potential to improve health and wellbeing.

Access free webinars and paid-for masterclasses.

NICE's technology appraisal and highly specialised technologies guidance manual

Our experts can offer advice and support in contextualising our guidelines, or helping you adapt our content to your country or local context.

An approximate guide to the timings for the development of a piece of HealthTech guidance.

Our Medical Technologies Evaluation Programme (MTEP) considers technologies that could offer benefits to patients and the health and social care system over current practice.

Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.

We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.

NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.

Day-to-day decision making is the responsibility of NICE's executive team.